跳至主要内容
临床试验/NCT06490861
NCT06490861招募中不适用

An Open Multi-centre Investigation to Evaluate the Performance of the Paragit Sleeve With build-in sEMG Sensors, Kinetic Sensors, and Smart-textile to Measure and Monitor Motor Symptoms and Treatment-induced Dyskinesia in Patients With Parkinson's Disease

Paragit ApS1 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2023年12月19日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
25
试验地点
1
主要终点
Dyskinesia

研究概览

简要总结

This investigation is undertaken to:

  • Evaluate the accuracy and reliability of the device in measuring and recording motor symptoms associated with Parkinson's Disease (PD), and
  • To assess the safety and tolerability of the device in patients with PD.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Parkinson disease: Clinically diagnosed
  • Age ≥ 50 (not in the childbearing aged as defined by Statistics Denmark, 15-49)
  • Experiencing at least two of following symptoms and/or side effect on a daily basis:
  • Bradykinesia
  • Dyskinesia (treatment side effect)
  • Provision of informed consent, i.e., the subject must be able to:
  • Read and understand the Patient Information and Consent Form
  • Sign the Patient Information and Consent Form.

排除标准

  • Known allergy/hypersensitivity to any material in direct contact with the skin (stainless steel, silicone and polyester)
  • Other neurological diseases

结局指标

主要结局

Dyskinesia

时间窗: During the clinical assessment, and for the following 24h.

The device will assess rigidity, measured with superficial EMG \[Volts\], and inertial measurement unit \[m/s2\]. Correlation with clinical gold-standard (MDS-UPDRS) will be studied.

Tremor

时间窗: During the clinical assessment, and for the following 24h.

Tremor will be assessed using the device, measured with superficial EMG \[Volts\], and inertial measurement unit \[m/s2\]. Correlation with clinical gold-standard (MDS-UPDRS) will be studied.

Bradykinesia

时间窗: During the clinical assessment, and for the following 24h.

Bradykinesia will be assessed using the device, measured inertial measurement unit \[m/s2\]. Correlation with clinical gold-standard (MDS-UPDRS) will be studied.

Rigidity

时间窗: During the clinical assessment, and for the following 24h.

The device will assess rigidity, measured with superficial EMG \[Volts\], and inertial measurement unit \[m/s2\]. Correlation with clinical gold-standard (MDS-UPDRS) will be studied.

次要结局

  • Usability(During the clinical assessment , and for the following 24h.)
  • Safety(During the clinical assessment , and for the following 24h.)

研究者

发起方
Paragit ApS
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验